Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
ophthalmology
age-related macular degeneration treatments for eye diseases |
| gptkbp:foundedIn |
2007
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ophthotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Fovista
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:renamed |
gptkb:IVERIC_bio
|
| gptkbp:stockSymbol |
gptkb:OPHT
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|